These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19491391)

  • 1. Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate.
    Chou ST; Khandros E; Bailey LC; Nichols KE; Vakoc CR; Yao Y; Huang Z; Crispino JD; Hardison RC; Blobel GA; Weiss MJ
    Blood; 2009 Jul; 114(5):983-94. PubMed ID: 19491391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1.
    Zhang P; Behre G; Pan J; Iwama A; Wara-Aswapati N; Radomska HS; Auron PE; Tenen DG; Sun Z
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8705-10. PubMed ID: 10411939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages.
    Arinobu Y; Mizuno S; Chong Y; Shigematsu H; Iino T; Iwasaki H; Graf T; Mayfield R; Chan S; Kastner P; Akashi K
    Cell Stem Cell; 2007 Oct; 1(4):416-27. PubMed ID: 18371378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PU.1 activation relieves GATA-1-mediated repression of Cebpa and Cbfb during leukemia differentiation.
    Burda P; Curik N; Kokavec J; Basova P; Mikulenkova D; Skoultchi AI; Zavadil J; Stopka T
    Mol Cancer Res; 2009 Oct; 7(10):1693-703. PubMed ID: 19825991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding.
    Zhang P; Zhang X; Iwama A; Yu C; Smith KA; Mueller BU; Narravula S; Torbett BE; Orkin SH; Tenen DG
    Blood; 2000 Oct; 96(8):2641-8. PubMed ID: 11023493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates.
    Walsh JC; DeKoter RP; Lee HJ; Smith ED; Lancki DW; Gurish MF; Friend DS; Stevens RL; Anastasi J; Singh H
    Immunity; 2002 Nov; 17(5):665-76. PubMed ID: 12433372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines.
    Matsumura I; Kawasaki A; Tanaka H; Sonoyama J; Ezoe S; Minegishi N; Nakajima K; Yamamoto M; Kanakura Y
    Blood; 2000 Oct; 96(7):2440-50. PubMed ID: 11001896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation.
    McIvor Z; Hein S; Fiegler H; Schroeder T; Stocking C; Just U; Cross M
    Exp Hematol; 2003 Jan; 31(1):39-47. PubMed ID: 12543105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PU.1 regulates TCR expression by modulating GATA-3 activity.
    Chang HC; Han L; Jabeen R; Carotta S; Nutt SL; Kaplan MH
    J Immunol; 2009 Oct; 183(8):4887-94. PubMed ID: 19801513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity.
    Kamath MB; Houston IB; Janovski AJ; Zhu X; Gowrisankar S; Jegga AG; DeKoter RP
    Leukemia; 2008 Jun; 22(6):1214-25. PubMed ID: 18354487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells.
    Rekhtman N; Radparvar F; Evans T; Skoultchi AI
    Genes Dev; 1999 Jun; 13(11):1398-411. PubMed ID: 10364157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA-2 reinforces megakaryocyte development in the absence of GATA-1.
    Huang Z; Dore LC; Li Z; Orkin SH; Feng G; Lin S; Crispino JD
    Mol Cell Biol; 2009 Sep; 29(18):5168-80. PubMed ID: 19620289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PU.1 Mimic Synthetic Peptides Selectively Bind with GATA-1 and Allow c-Jun PU.1 Binding to Enhance Myelopoiesis.
    Raghav PK; Gangenahalli G
    Int J Nanomedicine; 2021; 16():3833-3859. PubMed ID: 34113102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation.
    Rekhtman N; Choe KS; Matushansky I; Murray S; Stopka T; Skoultchi AI
    Mol Cell Biol; 2003 Nov; 23(21):7460-74. PubMed ID: 14559995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.
    Nerlov C; Graf T
    Genes Dev; 1998 Aug; 12(15):2403-12. PubMed ID: 9694804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the interaction between the hematopoietic master transcription factors GATA-1 and PU.1.
    Liew CW; Rand KD; Simpson RJ; Yung WW; Mansfield RE; Crossley M; Proetorius-Ibba M; Nerlov C; Poulsen FM; Mackay JP
    J Biol Chem; 2006 Sep; 281(38):28296-306. PubMed ID: 16861236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation.
    Moriguchi T; Yamamoto M
    Int J Hematol; 2014 Nov; 100(5):417-24. PubMed ID: 24638828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch signaling induces multilineage myeloid differentiation and up-regulates PU.1 expression.
    Schroeder T; Kohlhof H; Rieber N; Just U
    J Immunol; 2003 Jun; 170(11):5538-48. PubMed ID: 12759431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of lysophosphatidic acid receptors 2 and 3 regulates myeloid commitment of hematopoietic stem cells.
    Lin KH; Chiang JC; Chen WM; Ho YH; Yao CL; Lee H
    Am J Physiol Cell Physiol; 2021 Apr; 320(4):C509-C519. PubMed ID: 33406026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription.
    Nerlov C; Querfurth E; Kulessa H; Graf T
    Blood; 2000 Apr; 95(8):2543-51. PubMed ID: 10753833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.